Comment
doi: 10.1136/gut.2003.037309.
Fatty liver, hypertension, and the metabolic syndrome
Affiliations
- PMID: 15194635
- PMCID: PMC1774127
- DOI: 10.1136/gut.2003.037309
Item in Clipboard
Comment
Fatty liver, hypertension, and the metabolic syndrome
Gut.
2004 Jul.
Abstract
The prevalence of fatty liver in non-obese non-diabetic hypertensive patients is at least twice that of the general population and may be related to increases in insulin resistance and body weight.
Comment on
-
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance.Gut. 2004 Jul;53(7):1020-3. doi: 10.1136/gut.2003.027086. Gut. 2004. PMID: 15194655 Free PMC article.
Similar articles
-
Hypertension and hepatic steatosis.Curr Hypertens Rep. 2008 Jun;10(3):182-7. doi: 10.1007/s11906-008-0035-9. Curr Hypertens Rep. 2008. PMID: 18765087 Review.
-
Second World Congress on the Insulin Resistance Syndrome: insulin resistance syndrome and nonalcoholic fatty liver disease.Diabetes Care. 2005 Jun;28(6):1518-23. doi: 10.2337/diacare.28.6.1518. Diabetes Care. 2005. PMID: 15920084 No abstract available.
-
Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance.Gut. 2004 Jul;53(7):1020-3. doi: 10.1136/gut.2003.027086. Gut. 2004. PMID: 15194655 Free PMC article.
-
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P. Vojnosanit Pregl. 2016. PMID: 29327896
-
Hypertension and fatty liver: guilty by association?J Hum Hypertens. 2007 Apr;21(4):264-70. doi: 10.1038/sj.jhh.1002148. Epub 2007 Feb 1. J Hum Hypertens. 2007. PMID: 17273155 Review.
Cited by
-
Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease.Oxid Med Cell Longev. 2018 Jun 11;2018:9547613. doi: 10.1155/2018/9547613. eCollection 2018. Oxid Med Cell Longev. 2018. PMID: 29991976 Free PMC article. Review.
-
Bax inhibition protects against free fatty acid-induced lysosomal permeabilization.Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1339-46. doi: 10.1152/ajpgi.00509.2005. Epub 2006 Feb 16. Am J Physiol Gastrointest Liver Physiol. 2006. PMID: 16484678 Free PMC article.
-
Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults.J Clin Med. 2022 Feb 11;11(4):935. doi: 10.3390/jcm11040935. J Clin Med. 2022. PMID: 35207209 Free PMC article.
-
Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats.Am J Pathol. 2009 Apr;174(4):1329-37. doi: 10.2353/ajpath.2009.080697. Epub 2009 Feb 26. Am J Pathol. 2009. PMID: 19246643 Free PMC article.
-
Changes in Body Weight and Concurrent Changes in Cardiovascular Risk Profiles in Community Residents in Japan: the Hisayama Study.J Atheroscler Thromb. 2022 Feb 1;29(2):252-267. doi: 10.5551/jat.59394. Epub 2021 Jan 17. J Atheroscler Thromb. 2022. PMID: 33455974 Free PMC article.
References
-
- Bellentani S , Saccoccio G, Masutti F, et al. Prevalence of and risk factors for hepatic steatosis in Northern Italy. Ann Intern Med 2000;132:112–17. - PubMed
-
- Younossi Z , Diehl AM, Ong J. Nonalcoholic fatty lier disease: an agenda for clinical research. Hepatology 2002;35:746–52. - PubMed
-
- Powell EE, Cooksley GE, Hanson R, et al. The natural history of nonalcoholic steatohepatitis: A follow-up study of 42 patients follow for up to 21 years. Hepatology 1990;11:74–80. - PubMed
-
- Teli M , James OF, Burt AD, et al. A natural history of nonalcoholic fatty liver: A follow-up study. Hepatology 1995;22:1714–19. - PubMed
-
- Falck-Ytter Y , Younassi ZM, Marchesini G, et al. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis 2001;21:71–6. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
